These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 29868015)

  • 1. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
    Shim DW; Lee KH
    Front Immunol; 2018; 9():1054. PubMed ID: 29868015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of NLRP3 Inflammasome by Phosphorylation.
    Song N; Li T
    Front Immunol; 2018; 9():2305. PubMed ID: 30349539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 Ubiquitination-A New Approach to Target NLRP3 Inflammasome Activation.
    Akther M; Haque ME; Park J; Kang TB; Lee KH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation.
    Qin Y; Zhao W
    Eur J Immunol; 2023 Oct; 53(10):e2350382. PubMed ID: 37382218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
    Kim JK; Jin HS; Suh HW; Jo EK
    Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages.
    Kawashima A; Karasawa T; Tago K; Kimura H; Kamata R; Usui-Kawanishi F; Watanabe S; Ohta S; Funakoshi-Tago M; Yanagisawa K; Kasahara T; Suzuki K; Takahashi M
    J Immunol; 2017 Nov; 199(10):3614-3622. PubMed ID: 29021376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation.
    Qin Y; Li Q; Liang W; Yan R; Tong L; Jia M; Zhao C; Zhao W
    Nat Commun; 2021 Aug; 12(1):4794. PubMed ID: 34373456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational regulation of inflammasomes.
    Yang J; Liu Z; Xiao TS
    Cell Mol Immunol; 2017 Jan; 14(1):65-79. PubMed ID: 27345727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitochondria in NLRP3 inflammasome activation.
    Liu Q; Zhang D; Hu D; Zhou X; Zhou Y
    Mol Immunol; 2018 Nov; 103():115-124. PubMed ID: 30248487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in mechanisms for NLRP3 inflammasomes regulation].
    Liu W; Guo WJ; Xu Q; Sun Y
    Yao Xue Xue Bao; 2016 Oct; 51(10):1505-12. PubMed ID: 29924571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination.
    Shim DW; Shin WY; Yu SH; Kim BH; Ye SK; Koppula S; Won HS; Kang TB; Lee KH
    Sci Rep; 2017 Nov; 7(1):15020. PubMed ID: 29118366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.
    Stutz A; Kolbe CC; Stahl R; Horvath GL; Franklin BS; van Ray O; Brinkschulte R; Geyer M; Meissner F; Latz E
    J Exp Med; 2017 Jun; 214(6):1725-1736. PubMed ID: 28465465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation.
    Kelley N; Jeltema D; Duan Y; He Y
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation.
    Xia J; Jiang S; Dong S; Liao Y; Zhou Y
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the regulatory mechanisms of NLRP3 inflammasome activation.
    Paik S; Kim JK; Silwal P; Sasakawa C; Jo EK
    Cell Mol Immunol; 2021 May; 18(5):1141-1160. PubMed ID: 33850310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of the NLRP3 inflammasome].
    Groslambert M; Py BF
    Med Sci (Paris); 2018 Jan; 34(1):47-53. PubMed ID: 29384096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma.
    McKee CM; Coll RC
    J Leukoc Biol; 2020 Sep; 108(3):937-952. PubMed ID: 32745339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome in sepsis (Review).
    Shi X; Tan S; Tan S
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.